SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

NCT03589222 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Refractory Multiple Myeloma

Interventions

DRUG: Selinexor
DRUG: Daratumumab
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

PETHEMA Foundation